Investing Profile

Sevgi Gurkan

InvestorVC
Venture Partner at OrbiMed
orbimed.comSan Francisco Bay Area
Photo of Sevgi Gurkan, Venture Partner at OrbiMed

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4572 CONNECTIONS
Hotmail Network
4572 CONNECTIONS
Stanford University Network
250 CONNECTIONS
Merck Network
35 CONNECTIONS
Merck Network
35 CONNECTIONS
cb
OrbiMed Venture Partner
$1M - $75.0M
$4.0M
$18B
Associate Professor/Pediatric Nephrology Rutgers UniversityPresent
Physician Scientist HotmailPresent
Director, Pediatric Kidney Transplant Center HotmailPresent
Medical Director / Early Clinical Development MerckPresent
Group Lead / Director / Discovery Biology South San Francisco MerckPresent
Member Board of Directors Corteria PharmaceuticalsPresent
SPARK Advisor Stanford UniversityPresent
Venture Partner OrbiMedPresent
Founder, President and CEO Perfuse TherapeuticsPresent
Icahn School of Medicine at Mount Sinai Nephrology Translational research on mechanisms of graft tolerance
Icahn School of Medicine at Mount Sinai Master's degree Clinical Research